This cohort study uses National Cancer Database data to examine cancer antigen (CA) 125 levels at ovarian cancer diagnosis by patient race and ethnicity and whether elevated CA-125 levels are associated with timely treatment initiation. The gene discussed is MUC16; the disease is ovarian cancer.